We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...

One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...

With these trends in view, let’s look at the 7 most undervalued biotech stocks to invest in.

The state-of-the-art biologics facility, acquired by Syngene USA Inc., a wholly owned subsidiary of Syngene, from Emergent ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK ... View Research predicted that the value of pharmaceutical manufacturing worldwide was $516.48 billion in 2022.

Multinational pharmaceutical company GSK’s commitment to invest up to $800 million in its facility near Marietta may have ...

Carlyle Group's acquisition of bluebird bio for $3 per share offers a potential but unlikely $600 million sales milestone by ...

Shares of GSK plc (NYSE:GSK – Get Free Report) have been given an average rating of “Moderate Buy” by the ten brokerages that are presently covering the firm, Marketbeat.com reports.

Former Barrow and Furness MP Simon Fell chaired a taskforce which developed a vision for Ulverston Life Science and Advanced Manufacturing Park on the former GSK site, which had been tipped to ...

The pharmaceutical industry faces significantly longer lead times than other industries, and time delays can seriously impact the health outcomes of countless individuals. Recognizing the potential ...

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...